CompletedNCT02188121
Cardiovascular Risk Treatment for People With Serious Mental Illness
About this title
Read the official source — NCT02188121Medication studyAges 18–89United StatesSchizophrenia
Understand this study
Who was this study for?
Listed age limits: 18 years to 89 years.
- Listed locations
- BelmontSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateFebruary 2015
- Recruitment status
- Completed
- Enrollment listed in the registry
- 227
- Sponsor
- Mclean Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 89 Years
- Official registry ID
- NCT02188121
- Official title
Show the full official title
Fixed Dose Intervention Trial of New England Enhancing Survival in Serious Mental Illness Patients
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Belmont
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Mclean Hospital, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Simvastatin and Losartan.
Who was this study for?
Listed age limits: 18 years to 89 years.
